Skip to content
10-K

Annual Report

IGM Biosciences, Inc.

0000950170-25-034597

← back to feed
Filed
Mar 6, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted FY 2024 · Dec 31, 2024 60.51M sh
Shares Diluted FY 2024 · Dec 31, 2023 52.31M sh
Shares Diluted FY 2024 · Dec 31, 2022 41.54M sh
Capex FY 2024 · Dec 31, 2024 $5.85M
Capex FY 2024 · Dec 31, 2023 $12.38M
Capex FY 2024 · Dec 31, 2022 $10.21M
Operating Cash Flow FY 2024 · Dec 31, 2024 −$153M
Operating Cash Flow FY 2024 · Dec 31, 2023 −$192.23M
Operating Cash Flow FY 2024 · Dec 31, 2022 −$5.85M
Cash And Equivalents FY 2024 · Dec 31, 2024 $26.5M
Cash And Equivalents FY 2024 · Dec 31, 2023 $112.52M
Cash And Equivalents FY 2024 · Dec 31, 2022 $121.23M
Stockholders Equity FY 2024 · Dec 31, 2024 $48.17M
Stockholders Equity FY 2024 · Dec 31, 2023 $203.23M
Stockholders Equity FY 2024 · Dec 31, 2022 $287.26M
Stockholders Equity FY 2024 · Dec 31, 2021 $244.91M
Current Liabilities FY 2024 · Dec 31, 2024 $37.64M
Current Liabilities FY 2024 · Dec 31, 2023 $42.48M
Total Liabilities FY 2024 · Dec 31, 2024 $217.54M
Total Liabilities FY 2024 · Dec 31, 2023 $220.18M
Current Assets FY 2024 · Dec 31, 2024 $193.62M
Current Assets FY 2024 · Dec 31, 2023 $347.6M
Total Assets FY 2024 · Dec 31, 2024 $265.71M
Total Assets FY 2024 · Dec 31, 2023 $423.41M
Eps Diluted FY 2024 · Dec 31, 2024 −$3.24
Eps Diluted FY 2024 · Dec 31, 2023 −$4.71
Eps Diluted FY 2024 · Dec 31, 2022 −$5.32
Eps Basic FY 2024 · Dec 31, 2024 −$3.24
Eps Basic FY 2024 · Dec 31, 2023 −$4.71
Eps Basic FY 2024 · Dec 31, 2022 −$5.32
Sga Expense FY 2024 · Dec 31, 2024 $50.41M
Sga Expense FY 2024 · Dec 31, 2023 $50.07M
Sga Expense FY 2024 · Dec 31, 2022 $49.74M
Rd Expense FY 2024 · Dec 31, 2024 $160.85M
Rd Expense FY 2024 · Dec 31, 2023 $215.52M
Rd Expense FY 2024 · Dec 31, 2022 $179.29M
Net Income FY 2024 · Dec 31, 2024 −$195.8M
Net Income FY 2024 · Dec 31, 2023 −$246.42M
Net Income FY 2024 · Dec 31, 2022 −$221.1M
Operating Income FY 2024 · Dec 31, 2024 −$208.58M
Operating Income FY 2024 · Dec 31, 2023 −$263.46M
Operating Income FY 2024 · Dec 31, 2022 −$227.96M